These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20528755)
1. Peripheral blood derived cell trafficking for cardiac regeneration. Post S; Goumans MJ; Doevendans PA Curr Stem Cell Res Ther; 2010 Dec; 5(4):303-13. PubMed ID: 20528755 [TBL] [Abstract][Full Text] [Related]
2. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. Ghadge SK; Mühlstedt S; Ozcelik C; Bader M Pharmacol Ther; 2011 Jan; 129(1):97-108. PubMed ID: 20965212 [TBL] [Abstract][Full Text] [Related]
3. Cardiac stem cells and their roles in myocardial infarction. Hou J; Wang L; Jiang J; Zhou C; Guo T; Zheng S; Wang T Stem Cell Rev Rep; 2013 Jun; 9(3):326-38. PubMed ID: 23238707 [TBL] [Abstract][Full Text] [Related]
4. Cellular Therapy for Ischemic Heart Disease: An Update. Peng H; Abdel-Latif A Adv Exp Med Biol; 2019; 1201():195-213. PubMed ID: 31898788 [TBL] [Abstract][Full Text] [Related]
5. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Kastrup J; Ripa RS; Wang Y; Jørgensen E Eur Heart J; 2006 Dec; 27(23):2748-54. PubMed ID: 17065171 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Kawamoto A; Murayama T; Kusano K; Ii M; Tkebuchava T; Shintani S; Iwakura A; Johnson I; von Samson P; Hanley A; Gavin M; Curry C; Silver M; Ma H; Kearney M; Losordo DW Circulation; 2004 Sep; 110(11):1398-405. PubMed ID: 15337699 [TBL] [Abstract][Full Text] [Related]
7. Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cells. Lee N; Thorne T; Losordo DW; Yoon YS Cell Cycle; 2005 Jul; 4(7):861-4. PubMed ID: 15970686 [TBL] [Abstract][Full Text] [Related]
8. Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction. Srinivas G; Anversa P; Frishman WH Cardiol Rev; 2009; 17(1):1-9. PubMed ID: 19092364 [TBL] [Abstract][Full Text] [Related]
9. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Templin C; Lüscher TF; Landmesser U Int J Dev Biol; 2011; 55(4-5):407-17. PubMed ID: 21553380 [TBL] [Abstract][Full Text] [Related]
10. Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice. Nagata H; Ii M; Kohbayashi E; Hoshiga M; Hanafusa T; Asahi M Stem Cells Transl Med; 2016 Feb; 5(2):141-51. PubMed ID: 26683873 [TBL] [Abstract][Full Text] [Related]
11. Quo vadis, progenitor? Progenitor cell homing in chronic ischemic heart disease. Limbourg FP; Drexler H J Cardiovasc Pharmacol; 2009 Jun; 53(6):438-9. PubMed ID: 19433983 [No Abstract] [Full Text] [Related]
12. Cardiac stem cell therapy for myocardial regeneration. A clinical perspective. Dawn B; Zuba-Surma EK; Abdel-Latif A; Tiwari S; Bolli R Minerva Cardioangiol; 2005 Dec; 53(6):549-64. PubMed ID: 16333238 [TBL] [Abstract][Full Text] [Related]
13. CD34+ cell mobilization and upregulation of myocardial cytokines in a rabbit model of myocardial ischemia. Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Yuan Z; Liu Z Int J Cardiol; 2011 Oct; 152(1):18-23. PubMed ID: 20624659 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015). Singh A; Singh A; Sen D Stem Cell Res Ther; 2016 Jun; 7(1):82. PubMed ID: 27259550 [TBL] [Abstract][Full Text] [Related]
15. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Jackson KA; Majka SM; Wang H; Pocius J; Hartley CJ; Majesky MW; Entman ML; Michael LH; Hirschi KK; Goodell MA J Clin Invest; 2001 Jun; 107(11):1395-402. PubMed ID: 11390421 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived stem cell therapy in ischemic heart disease. Cho HJ; Lee J; Wecker A; Yoon YS Regen Med; 2006 May; 1(3):337-45. PubMed ID: 17465787 [TBL] [Abstract][Full Text] [Related]
17. Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction. Dedobbeleer C; Blocklet D; Toungouz M; Lambermont M; Unger P; Degaute JP; Goldman S; Berkenboom G J Cardiovasc Pharmacol; 2009 Jun; 53(6):480-5. PubMed ID: 19433985 [TBL] [Abstract][Full Text] [Related]
18. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. Chavakis E; Urbich C; Dimmeler S J Mol Cell Cardiol; 2008 Oct; 45(4):514-22. PubMed ID: 18304573 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction. Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641 [TBL] [Abstract][Full Text] [Related]
20. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Wojakowski W; Tendera M Folia Histochem Cytobiol; 2005; 43(4):229-32. PubMed ID: 16382890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]